Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Total Assets : ¥3,374 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Chengdu Easton Biopharmaceuticals Co Total Assets?

Chengdu Easton Biopharmaceuticals Co's Total Assets for the quarter that ended in Mar. 2024 was ¥3,374 Mil.

During the past 12 months, Chengdu Easton Biopharmaceuticals Co's average Total Assets Growth Rate was 8.60% per year. During the past 3 years, the average Total Assets Growth Rate was 26.30% per year. During the past 5 years, the average Total Assets Growth Rate was 36.10% per year.

During the past 8 years, Chengdu Easton Biopharmaceuticals Co's highest 3-Year average Total Assets Growth Rate was 44.10%. The lowest was 25.80%. And the median was 41.60%.

Total Assets is connected with ROA %. Chengdu Easton Biopharmaceuticals Co's annualized ROA % for the quarter that ended in Mar. 2024 was 8.93%. Total Assets is also linked to Revenue through Asset Turnover. Chengdu Easton Biopharmaceuticals Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.09.

Chengdu Easton Biopharmaceuticals Co Total Assets Historical Data

The historical data trend for Chengdu Easton Biopharmaceuticals Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Easton Biopharmaceuticals Co Total Assets Chart

Chengdu Easton Biopharmaceuticals Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

987.08

2,530.86

2,775.27

3,017.54

3,346.75

Chengdu Easton Biopharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															3,098.77	3,085.44	3,215.97	3,346.75	3,374.37

Chengdu Easton Biopharmaceuticals Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Chengdu Easton Biopharmaceuticals Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	2603.42	+	743.334
	=	3,347

Chengdu Easton Biopharmaceuticals Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	2626.11	+	748.261
	=	3,374

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Total Assets Explanation

Total Assets is connected with ROA %.

Chengdu Easton Biopharmaceuticals Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	300.04	/	( (3346.754	+	3374.371)	/ 2 )
	=	300.04	/	3360.5625
	=	8.93 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Chengdu Easton Biopharmaceuticals Co's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	314.99	/	( (3346.754	+	3374.371)	/ 2 )
=	314.99	/	3360.5625
=	0.09

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Chengdu Easton Biopharmaceuticals Co Total Assets Related Terms

Thank you for viewing the detailed overview of Chengdu Easton Biopharmaceuticals Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Easton Biopharmaceuticals Co Ltd (SHSE:688513) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 8, Xiyuan Avenue, Chengdu High-tech Zone, Sichuan Province, Chengdu, CHN, 611731

Website

http://www.eastonpharma.cn

Chengdu Easton Biopharmaceuticals Co Ltd is engaged in research and development, production and sales of chemical raw materials and chemical pharmaceutical preparations. The company's products range from Active Pharmaceutical Ingredient to finish dosage forms like capsules, tablets and injections, enabling us to take R&D discovery to industrial level, solving problems during the course of R&D, production and distribution. Its products are categorized under Active Pharmaceutical Ingredients and Fixed Dose Formulation.

Chengdu Easton Biopharmaceuticals Co (SHSE:688513) Headlines

No Headlines